Methods: This was a retrospective study including 535 consecutive patients who underwent AWR with underlay acellular dermal matrix (ADM) mesh. Four hundred eighty-four (90.47%) patients underwent mesh-reinforced AWR and 51 (9.53%) underwent bridged-repair AWR. Propensity score analysis was used for risk adjustment in multivariate analysis and for one-to-one matching to control for confounding differences between treatment groups. [Au: Suggest stating the p value at which results were considered significant.]
Results: Bridged repairs had poorer long-term results than mesh-reinforced AWR, with a higher recurrent hernia rate (33.3% vs 6.2%, p=0.001), higher overall complication rate (58.8% vs 30.0%, p=0.001), and shorter freedom from hernia recurrence (log-rank <0.001). Bridged-repair AWR patients also experienced higher wound dehiscence rates (25.5% vs 14.3%, p=0.034) and mesh exposure rates (9.8% vs 1.4%, p=0.003) than mesh-reinforced AWR patients.
When the treatment method was adjusted for propensity score among the 100 propensity-score-matched pairs, the recurrent hernia rate (32.0% vs 6.0%, p=0.002), overall complication rate (68.2% vs 31.8%, p=0.001), and freedom from hernia recurrence (log-rank =0.005) remained poorer after bridged-repair AWR. However, we no longer observed differences in wound healing and mesh complications.
Conclusions: Bridged repair for AWR is associated with significantly higher hernia recurrence and overall complication rates than mesh-reinforced AWR, ever after adjusting for differences between the comparison groups. Whenever possible, bridged repair should be avoided in AWR.